LifeStance Health (LFST) Accumulated Expenses (2020 - 2026)

LifeStance Health (LFST) has 7 years of Accumulated Expenses data on file, last reported at $117.3 million in Q1 2026.

• Quarterly Accumulated Expenses rose 17.4% year-over-year to $117.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $117.3 million (up 17.4% YoY) and the FY2025 annual result came in at $143.3 million, up 22.02% from the prior year.
• Accumulated Expenses slipped to $117.3 million in Q1 2026 per LFST's latest filing, from $143.3 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $143.3 million in Q4 2025 and bottomed at $61.2 million in Q2 2022.
• The 5-year median for Accumulated Expenses is $100.4 million (2024), against an average of $98.7 million.
• The widest annual swing landed in 2024, when Accumulated Expenses soared 51.06%; it then retreated 0.51% in 2025.
• Tracing LFST's Accumulated Expenses over 5 years: stood at $75.6 million in 2022, then soared by 35.46% to $102.5 million in 2023, then increased by 14.62% to $117.5 million in 2024, then advanced by 22.02% to $143.3 million in 2025, then slipped by 18.15% to $117.3 million in 2026.
• Per Business Quant, the three latest LFST Accumulated Expenses figures stand at $117.3 million (Q1 2026), $143.3 million (Q4 2025), and $113.8 million (Q3 2025).

Peer Comparison